Company Filing History:
Years Active: 2000-2003
Title: Innovations of Bei B Zhang in Antidiabetic Research
Introduction
Bei B Zhang is a notable inventor based in Edison, NJ (US), recognized for his contributions to the field of antidiabetic research. He holds a total of 3 patents, showcasing his commitment to developing innovative solutions for diabetes management.
Latest Patents
Among his latest patents, Zhang has developed antidiabetic 4-hydroxy-2-furoic acids. These substituted compounds are derived from the fermentation of an asterriquinone, a natural product characterized by a 2,5-dioxy-3,6-bis(indolyl)quinone structure. These compounds have been shown to modulate insulin receptor tyrosine kinase activity, potentially offering therapeutic benefits for diabetes and other conditions associated with impaired insulin production or response. Additionally, he has patented various antidiabetic agents, which include compounds of formula I and their tautomers, pharmaceutically acceptable salts, hydrates, prodrugs, and reduced forms. These compounds are particularly useful in treating and preventing diabetes mellitus, especially in managing hyperglycemia in diabetic patients.
Career Highlights
Zhang is currently affiliated with Merck & Company, Inc., where he continues to advance his research in diabetes treatment. His work has significantly contributed to the understanding and development of new therapeutic agents aimed at improving the lives of those affected by diabetes.
Collaborations
Zhang has collaborated with esteemed colleagues, including Shieh-Shung T Chen and Xiaohua Li, who have contributed to his research endeavors.
Conclusion
Bei B Zhang's innovative work in antidiabetic research highlights his dedication to improving diabetes treatment through scientific advancements. His patents reflect a significant contribution to the field, aiming to enhance the quality of life for individuals living with diabetes.